Assessment of Hard and Soft Tissue Changes Following XCM Versus FGG Simultaneous With Dental Implant Placement
Launched by CAIRO UNIVERSITY · Jul 22, 2025
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods to help improve the gums and bone around dental implants for people who have lost teeth. When a tooth is lost, the area where it used to be can shrink and lose important gum tissue, which can make it harder for implants to stay healthy over time. The study is comparing two techniques—using a special soft tissue graft called XCM versus a traditional gum graft called FGG—both done at the same time as placing the dental implant. The goal is to find out which method better supports the gums and bone, helping implants last longer and stay healthy.
Adults over 18 who have a narrow band of firm gum tissue (2 millimeters or less) around the missing tooth area and enough bone to place an implant may be eligible to join. Participants need to have good oral hygiene and be willing to follow treatment instructions. People with active gum disease, infections, certain medical conditions, heavy smoking habits, or other health issues may not qualify. If you take part, you can expect to have the gum tissue around your implant treated using one of the two methods, and your healing and tissue changes will be carefully monitored. This study aims to help improve care for people needing implants by finding the best way to support healthy gums and bone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adults above the age of 18 years.
- • 2. Presence of 2mm or less of keratinized tissue width
- • 3. Sufficient alveolar ridge width minimum of 6 mm
- • 4. Patients with good oral hygiene as evidenced by plaque index (PI)\<1 and showing cooperation or compliance with treatment.
- Exclusion Criteria:
- • 1. Patients diagnosed with periodontal diseases (Caton et al., 2018).
- • 2. Acute active infection at implant sites
- • 3. Patients with medical conditions that would compromise the surgical procedures; uncontrolled diabetes mellitus, taking intravenous bisphosphonates for treatment of osteoporosis and radiotherapy
- • 4. Patients with parafunctional habits.
- • 5. Smokers (≥10 cigarettes per day),
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Parryhan M Abdelsamie, PhD
Principal Investigator
MTI University
Maged M Seleet, PhD
Principal Investigator
MTI University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported